Search by Drug Name or NDC
NDC 00115-1751-08 Acitretin 17.5 mg/1 Details
Acitretin 17.5 mg/1
Acitretin is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals of New York LLC. The primary component is ACITRETIN.
MedlinePlus Drug Summary
Acitretin is used to treat severe psoriasis (abnormal growth of skin cells that causes red, thickened, or scaly skin). Acitretin is in a class of medications called retinoids. The way acitretin works is not known.
Related Packages: 00115-1751-08Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Acitretin
Product Information
| NDC | 00115-1751 |
|---|---|
| Product ID | 0115-1751_80d24efe-d863-40f0-bd2b-85718f6ad568 |
| Associated GPIs | 90250510000115 |
| GCN Sequence Number | 065967 |
| GCN Sequence Number Description | acitretin CAPSULE 17.5 MG ORAL |
| HIC3 | L1A |
| HIC3 Description | ANTIPSORIATIC AGENTS,SYSTEMIC |
| GCN | 28108 |
| HICL Sequence Number | 007827 |
| HICL Sequence Number Description | ACITRETIN |
| Brand/Generic | Generic |
| Proprietary Name | Acitretin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Acitretin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 17.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | ACITRETIN |
| Labeler Name | Amneal Pharmaceuticals of New York LLC |
| Pharmaceutical Class | Retinoid [EPC], Retinoids [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA202552 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00115-1751-08 (00115175108)
| NDC Package Code | 0115-1751-08 |
|---|---|
| Billing NDC | 00115175108 |
| Package | 30 CAPSULE in 1 BOTTLE, PLASTIC (0115-1751-08) |
| Marketing Start Date | 2016-01-04 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |